| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |